By Mat Southwell, Shaun Shelly, Virginia MacDonald, Annette Verster, Lisa Maher

There is an urgent need to bring existing harm reduction programmes to scale and to broaden their scope, as well to complement them with innovative interventions targeting new populations and new substances. Under and disinvestment in harm reduction and the absence of enabling legal environments threatens to undermine the global HIV response and exacerbate the morbidity and mortality associated with the current epidemic of opioid overdose.

Click here to read the full article (restricted access)